Literature DB >> 17097831

Estimating differences in volumetric flat bone growth in pediatric patients by radiation treatment method.

Chiaho Hua1, Hemant I Shukla, Thomas E Merchant, Matthew J Krasin.   

Abstract

PURPOSE: To estimate potential differences in volumetric bone growth in children with sarcoma treated with intensity-modulated (IMRT) and conformal (CRT) radiation therapy using an empiric dose-effect model. METHODS AND MATERIALS: A random coefficient model was used to estimate potential volumetric bone growth of 36 pelvic bones (ischiopubis and ilium) from 11 patients 4 years after radiotherapy. The model incorporated patient age, pretreatment bone volume, integral dose >35 Gy, and time since completion of radiation therapy. Three dosimetry plans were entered into the model: the actual CRT/IMRT plan, a nontreated comparable IMRT/CRT plan, and an idealized plan in which dose was delivered only to the planning target volume. The results were compared with modeled normal bone growth.
RESULTS: The model predicted that by using the idealized, IMRT, and CRT approaches, patients would maintain 93%, 87%, and 84%, respectively (p = 0.06), of their expected normal growth. Patients older than 10 years would maintain 98% of normal growth, regardless of treatment method. Those younger than 10 years would maintain 87% (idealized), 76% (IMRT), or 70% (CRT) of their expected growth (p = 0.015). Post hoc testing (Tukey) revealed that the CRT and IMRT approaches differed significantly from the idealized one but not from each other.
CONCLUSIONS: Dose-effect models facilitate the comparison of treatment methods and potential interventions. Although treatment methods do not alter the growth of flat bones in older pediatric patients, they may significantly impact bone growth in children younger than age 10 years, especially as we move toward techniques with high conformity and sharper dose gradient.

Entities:  

Mesh:

Year:  2006        PMID: 17097831     DOI: 10.1016/j.ijrobp.2006.08.069

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Early Axial Growth Outcomes of Pediatric Patients Receiving Proton Craniospinal Irradiation.

Authors:  Brian De; Oren Cahlon; Kevin Sine; Dennis Mah; Eugen B Hug; Suzanne L Wolden
Journal:  J Pediatr Hematol Oncol       Date:  2018-11       Impact factor: 1.289

Review 2.  Children's Oncology Group's 2013 blueprint for research: radiation oncology.

Authors:  Thomas E Merchant; David Hodgson; Nadia N I Laack; Suzanne Wolden; Danny J Indelicato; John A Kalapurakal
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

3.  Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?

Authors:  John T Lucas; M Beth McCarville; David A Cooper; Mikhail Doubrovin; Daniel Wakefield; Teresa Santiago; Yimei Li; Xingyu Li; Matthew Krasin; Victor Santana; Wayne Furman; Andrew M Davidoff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-26       Impact factor: 7.038

4.  Late toxicity and outcomes following radiation therapy for chest wall sarcomas in pediatric patients.

Authors:  John T Lucas; Israel Fernandez-Pineda; Christopher L Tinkle; Michael W Bishop; Sue C Kaste; Rajiv Heda; Andrew M Davidoff; Matthew J Krasin
Journal:  Pract Radiat Oncol       Date:  2017-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.